BFEC
ACOR

Benjamin F. Edwards & Company’s Acorda Therapeutics ACOR Stock Holding History

Benjamin F. Edwards & Company’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-4
Closed -$13K – 1161
2016
Q2 		$13K Hold
4
– – ﹤0.01% 748
2016
Q1 		$13K Hold
4
– – ﹤0.01% 763
2015
Q4 		$21K Hold
4
– – ﹤0.01% 685
2015
Q3 		$13K Hold
4
– – ﹤0.01% 818
2015
Q2 		$17K Hold
4
– – ﹤0.01% 819
2015
Q1 		$17K Hold
4
– – ﹤0.01% 794
2014
Q4 		$20K Hold
4
– – ﹤0.01% 679
2014
Q3 		$17K Sell
4
-3
-43% -$11.3K ﹤0.01% 687
2014
Q2 		$29K Hold
7
– – 0.01% 550
2014
Q1 		$32K Buy
+7
New +$28.3K 0.01% 507

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Benjamin F. Edwards & Company's ACOR Position: Q3 2016 in Review

Benjamin F. Edwards & Company sold out of Acorda Therapeutics (ACOR) in Q3 2016, closing a stake of 4 shares — an estimated $13K sold.

Benjamin F. Edwards & Company first reported a position in ACOR in Q1 2014 and held it in 10 quarters. The position peaked at $32K in Q1 2014. 167 funds tracked by Wall St. Rank hold ACOR as of Q3 2016.

  • Benjamin F. Edwards & Company reported no remaining Acorda Therapeutics position as of Q3 2016 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 4 Acorda Therapeutics shares in Q3 2016, an estimated $13K.
  • Benjamin F. Edwards & Company first reported a position in Acorda Therapeutics in Q1 2014 and held it in 10 quarters.
  • Benjamin F. Edwards & Company's Acorda Therapeutics position peaked at $32K in Q1 2014.
  • 167 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q3 2016.

Based on Benjamin F. Edwards & Company's 13F filing for Q3 2016, filed 24 Oct 2016.